Daily Briefing

Fewer than half of US parents plan full vaccinations for kids


Fewer than half of pregnant women and parents of young children in the United States plan on fully vaccinating their child, according to recent survey data from researchers at CDC and Emory University published in JAMA Network Open.

Survey details

For the two surveys, researchers recruited 174 pregnant women and 1,765 parents from a nationally representative panel in April 2024 to answer questions about their intentions to have their child receive all recommended vaccines by the age of 18 months.

In total, 37.6% of pregnancies were first pregnancies. Around half of respondents held a bachelor's degree or higher, and just under 80% lived in urban areas.

The surveys found that fewer than half of respondents said they intend to fully vaccinate their child. Intent to vaccinate was similar among pregnant women and parents of young children, at 35% to 40%.

The proportion of respondents planning to refuse some or all vaccines was lowest among women who were pregnant for the first time (4%) and highest among parents of young children (33%).

Forty-eight percent of women in their first pregnancy were uncertain about childhood vaccinations, the most of any group, while just 4% of parents of young children said the same.

"Many parents in the U.S. choose to delay or refuse vaccines that are recommended for their child from birth to age 18 months," the researchers wrote. "Research is necessary to understand the value of intervening during pregnancy to proactively support parents with vaccination decisions before the birth of the child, as implementation of such interventions will require substantial engagement of health care professionals and entities outside of the pediatric care setting."

Discussion

The new study comes as many health officials have expressed concerns about growing vaccine hesitancy in the United States and its potential consequences, especially given the growing number of measles cases in the country.

Earlier this month, the United States confirmed over 1,200 measles cases so far this year, nearly 4.5 times greater than last year's total and the highest annual count since the disease was declared eliminated in 2000.

Children are routinely vaccinated for measles at 12 to 15 months and again at 4 to 6 years old, but children as young as 6 months old can receive the measles vaccine if they're deemed at risk.

Health officials continue to advocate for the measles, mumps, and rubella vaccine as the most effective was to combat the disease, as they have been shown to be 97% effective in preventing illness and further spread of the disease. CDC reported that just 8% of children who had a confirmed case of measles during the current outbreak had a known measles vaccination.

The study authors wrote that given the high level of uncertainty regarding childhood vaccinations during pregnancy, "there may be value in intervening during pregnancy to proactively support families with childhood vaccination decisions."

"Future interventions should account for differences in uptake of seasonal (i.e., COVID-19, influenza) vs routinely recommended vaccines," the researchers added. "Future studies with longitudinal follow-up may shed further light on evolution of vaccination decisions from pregnancy to parenthood, and the effectiveness of intervening proactively during pregnancy."

(Van Beusekom, CIDRAP News, 7/17; Boggs, Scripps News, 7/20)


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.